Who should be prioritized for COVID-19 vaccination in China? A descriptive study

BACKGROUND: All countries are facing decisions about which population groups to prioritize for access to COVID-19 vaccination after the first vaccine products have been licensed, at which time supply shortages are inevitable. Our objective is to define the key target populations, their size, and pri...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Med
Autori principali: Yang, Juan, Zheng, Wen, Shi, Huilin, Yan, Xuemei, Dong, Kaige, You, Qian, Zhong, Guangjie, Gong, Hui, Chen, Zhiyuan, Jit, Mark, Viboud, Cecile, Ajelli, Marco, Yu, Hongjie
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7872877/
https://ncbi.nlm.nih.gov/pubmed/33563270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-01923-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi